Suppr超能文献

五种自由循环的微小RNA和骨组织微小RNA与骨质疏松性骨折相关。

Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures.

作者信息

Seeliger Claudine, Karpinski Katrin, Haug Alexander T, Vester Helen, Schmitt Andreas, Bauer Jan S, van Griensven Martijn

机构信息

Department of Experimental Trauma Surgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

出版信息

J Bone Miner Res. 2014 Aug;29(8):1718-28. doi: 10.1002/jbmr.2175.

Abstract

Osteoporosis as a systemic skeletal disorder is characterized by increased bone fragility and the risk of fractures. According to the World Health Organization, osteoporosis is one of the 10 most common diseases and affects approximately 75 million people in Europe, the United States, and Japan. In this context, the identification of specific microRNA (miRNA) signatures is an important step for new diagnostic and therapeutic approaches. The focus of interest on miRNAs as biomarkers came with new publications identifying free circulating extracellular miRNAs associated with various types of cancer. This study aimed to identify specific miRNAs in patients with osteoporotic fractures compared with nonosteoporotic fractures. For the array analysis, miRNAs were isolated from the serum of 20 patients with hip fractures, transcribed, and the samples were pooled into 10 osteoporotic and 10 nonosteoporotic specimens. With each pool of samples, human serum and plasma miRNA PCR arrays were performed, which are able to identify 83 different miRNAs. Subsequently, a separate validation analysis of each miRNA found to be regulated in the array followed with miRNA samples isolated from the serum of 30 osteoporotic and 30 nonosteoporotic patients and miRNA samples isolated from the bone tissue of 20 osteoporotic and 20 nonosteoporotic patients. With the validation analysis of the regulated miRNAs, we identified 9 miRNAs, namely miR-21, miR-23a, miR-24, miR-93, miR-100, miR-122a, miR-124a, miR-125b, and miR-148a, that were significantly upregulated in the serum of patients with osteoporosis. In the bone tissue of osteoporotic patients, we identified that miR-21, miR-23a, miR-24, miR-25, miR-100, and miR-125b displayed a significantly higher expression. A total of 5 miRNAs display an upregulation both in serum and bone tissue. This study reveals an important role for several miRNAs in osteoporotic patients and suggested that they may be used as biomarkers for diagnostic purposes and may be a target for treating bone loss and optimizing fracture healing in osteoporotic patients.

摘要

骨质疏松症作为一种全身性骨骼疾病,其特征是骨脆性增加和骨折风险升高。根据世界卫生组织的数据,骨质疏松症是10种最常见的疾病之一,在欧洲、美国和日本约有7500万人受其影响。在此背景下,识别特定的微小RNA(miRNA)特征是开发新诊断和治疗方法的重要一步。随着新的研究发现游离循环细胞外miRNA与各种类型癌症相关,miRNA作为生物标志物受到了关注。本研究旨在识别骨质疏松性骨折患者与非骨质疏松性骨折患者体内特定的miRNA。在阵列分析中,从20例髋部骨折患者的血清中分离出miRNA,进行转录,然后将样本合并为10份骨质疏松症样本和10份非骨质疏松症样本。对每组样本进行人血清和血浆miRNA PCR阵列检测,该检测能够识别83种不同的miRNA。随后,对在阵列中发现表达有变化的每个miRNA进行单独的验证分析,分析样本来自30例骨质疏松症患者和30例非骨质疏松症患者的血清,以及20例骨质疏松症患者和20例非骨质疏松症患者的骨组织。通过对这些有变化的miRNA进行验证分析,我们鉴定出9种miRNA,即miR-21、miR-23a、miR-24、miR-93、miR-100、miR-122a、miR-124a、miR-125b和miR-148a,它们在骨质疏松症患者血清中显著上调。在骨质疏松症患者的骨组织中,我们发现miR-21、miR-23a、miR-24、miR-25、miR-100和miR-125b表达明显更高。共有5种miRNA在血清和骨组织中均上调。本研究揭示了几种miRNA在骨质疏松症患者中发挥的重要作用,并表明它们可能用作诊断生物标志物,还可能成为治疗骨质疏松症患者骨质流失和优化骨折愈合的靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验